Clinical outcomes of the post-closure technique for arteriotomy closure with the Impella cardiac power percutaneous left ventricular assist device.

IF 1.6 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Kevin J John, Haval Chweich, Carey Kimmelstiel, Charles D Resor, Navin K Kapur
{"title":"Clinical outcomes of the post-closure technique for arteriotomy closure with the Impella cardiac power percutaneous left ventricular assist device.","authors":"Kevin J John, Haval Chweich, Carey Kimmelstiel, Charles D Resor, Navin K Kapur","doi":"10.25270/jic/24.00168","DOIUrl":null,"url":null,"abstract":"<p><p>With the increasing utilization of endovascular mechanical circulatory support devices, such as the Impella CP (Abiomed), there is a need for standardized guidelines for its safe removal. Development of the Perclose post-closure technique was facilitated by the introduction of a new Impella repositioning sheath in 2019, which enabled re-access to the sidearm and stylet, rewiring of the access artery, and Impella sheath removal. Our retrospective single-center study included all patients undergoing Perclose post-closure technique for vascular access closure after Impella removal between 2018 and 2024. Forty-six patients, with a mean age of 63.8 years, predominantly male (82.6%), were included in the analysis. Indications for Impella placement included complex percutaneous coronary intervention (34.8%) and cardiogenic shock (CS) (heart failure-CS: 32.6%, myocardial infarction-CS: 21.7%). Clinically relevant complications were encountered in less than 5% of cases. No instances of covered stent placement, fasciotomy, amputation, or access site infections were reported. Our study underscores the safety of the Perclose post-closure technique following Impella removal in a diverse cohort of patients, with an overall clinically significant complication rate of less than 5%. The Perclose post-closure technique is a reliable and well-tolerated method for vascular access closure in patients undergoing Impella support.</p>","PeriodicalId":49261,"journal":{"name":"Journal of Invasive Cardiology","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Invasive Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25270/jic/24.00168","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

With the increasing utilization of endovascular mechanical circulatory support devices, such as the Impella CP (Abiomed), there is a need for standardized guidelines for its safe removal. Development of the Perclose post-closure technique was facilitated by the introduction of a new Impella repositioning sheath in 2019, which enabled re-access to the sidearm and stylet, rewiring of the access artery, and Impella sheath removal. Our retrospective single-center study included all patients undergoing Perclose post-closure technique for vascular access closure after Impella removal between 2018 and 2024. Forty-six patients, with a mean age of 63.8 years, predominantly male (82.6%), were included in the analysis. Indications for Impella placement included complex percutaneous coronary intervention (34.8%) and cardiogenic shock (CS) (heart failure-CS: 32.6%, myocardial infarction-CS: 21.7%). Clinically relevant complications were encountered in less than 5% of cases. No instances of covered stent placement, fasciotomy, amputation, or access site infections were reported. Our study underscores the safety of the Perclose post-closure technique following Impella removal in a diverse cohort of patients, with an overall clinically significant complication rate of less than 5%. The Perclose post-closure technique is a reliable and well-tolerated method for vascular access closure in patients undergoing Impella support.

Impella 心脏动力经皮左心室辅助装置动脉切口闭合术后的临床效果。
随着血管内机械循环支持装置(如 Impella CP(Abiomed))的使用率越来越高,有必要制定安全移除该装置的标准化指南。2019年推出的新型Impella复位鞘促进了Perclose术后关闭技术的发展,这种鞘可以重新接入挎管和支架、重新连接入路动脉并移除Impella鞘。我们的回顾性单中心研究纳入了 2018 年至 2024 年期间接受 Perclose 后封闭技术进行 Impella 拔除后血管通路封闭的所有患者。分析共纳入 46 名患者,平均年龄为 63.8 岁,主要为男性(82.6%)。植入 Impella 的适应症包括复杂的经皮冠状动脉介入治疗(34.8%)和心源性休克(CS)(心衰-CS:32.6%,心肌梗死-CS:21.7%)。出现临床相关并发症的病例不到 5%。无覆盖支架置入、筋膜切开、截肢或入路部位感染的报道。我们的研究强调了 Perclose 后封闭技术在不同患者群中摘除 Impella 后的安全性,总体临床重大并发症发生率低于 5%。Perclose后封闭技术是一种可靠且耐受性良好的方法,适用于接受Impella支持的患者的血管通路封闭。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Invasive Cardiology
Journal of Invasive Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.90
自引率
6.70%
发文量
214
审稿时长
3-8 weeks
期刊介绍: The Journal of Invasive Cardiology will consider for publication suitable articles on topics pertaining to the invasive treatment of patients with cardiovascular disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信